TG Therapeutics (TGTX) added ~6% pre-market Friday after Cantor Fitzgerald projected strong Q2 2023 sales for its multiple sclerosis drug
https://seekingalpha.com/news/3986212-tg-therapeutics-stock-rises-cantor-touts-briumvi-sales
TG Therapeutics (TGTX) added ~6% pre-market Friday after Cantor Fitzgerald projected strong Q2 2023 sales for its multiple sclerosis drug
https://seekingalpha.com/news/3986212-tg-therapeutics-stock-rises-cantor-touts-briumvi-sales
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.